Voxar's latest 3D version 4.2 has been integrated into Agfa's PACS solution, Impax. The integration is the result of a global distribution agreement that Agfa and Voxar signed late last year. The new software allows PET visualization and simultaneous
Voxar's latest 3D version 4.2 has been integrated into Agfa's PACS solution, Impax. The integration is the result of a global distribution agreement that Agfa and Voxar signed late last year. The new software allows PET visualization and simultaneous comparison of PET and CT images, as well as state-of-the-art image enhancement and measurement tools. One-click processes allow 2D, 3D, maximum-intensity projection, and multiplanar reconstruction. Automatic MPR Shape Selection enables selection, measurement, and display of complex heterogeneous structures. Protected health information is stripped from DICOM images using features integral to the application.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.